J.P. Marvel Investment Advisors LLC decreased its stake in shares of Solventum Co. (NYSE:SOLV – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,106 shares of the company’s stock after selling 673 shares during the period. J.P. Marvel Investment Advisors LLC’s holdings in Solventum were worth $668,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Modus Advisors LLC bought a new position in Solventum during the fourth quarter valued at approximately $25,000. Copeland Capital Management LLC bought a new position in Solventum in the third quarter worth approximately $26,000. Stonebridge Financial Group LLC bought a new position in Solventum in the fourth quarter worth approximately $26,000. Crews Bank & Trust bought a new position in Solventum in the fourth quarter worth approximately $32,000. Finally, True Wealth Design LLC raised its position in Solventum by 23,550.0% in the third quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after acquiring an additional 471 shares during the period.
Analysts Set New Price Targets
Several research firms have weighed in on SOLV. Piper Sandler increased their price target on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Mizuho began coverage on shares of Solventum in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price target on the stock. Finally, Morgan Stanley increased their price target on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $68.29.
Solventum Stock Down 0.4 %
SOLV opened at $74.04 on Friday. The company has a fifty day moving average of $70.75 and a 200 day moving average of $68.51. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $96.05. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45.
About Solventum
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Featured Stories
- Five stocks we like better than Solventum
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- The 3 Best Fintech Stocks to Buy Now
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.